Refeyn announces appointment of Fiona Coats as Chief Marketing Officer

FHS
May 22, 2024
3:47 pm

Refeyn, the company behind pioneering mass photometry technologies, is delighted to announce the appointment of Fiona Coats as Chief Marketing Officer, effective from June, 2024.

New Extended-Release Parkinson’s Drug Approved

The FDA approved an oral extended-release formulation of levodopa and carbidopa known as IPX203 (Crexont) to treat Parkinson’s disease, Amneal Pharmaceuticals announced Wednesday. The treatment

August 9, 2024

I swore I wouldn’t become a psychiatrist

I entered medical school absolutely certain of one thing: I didn’t want to be a psychiatrist like my father. I’m sure someone like Freud could

October 11, 2024

Postpartum Dads; Obits Now Naming Suicide; N.J. Doubles Involuntary Hold Time

One in 10 dads experience postpartum depression and anxiety. (USA Today) This is the last week the FDA is accepting comments on its new guidance

August 24, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.